Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vector-Based Gene Therapy Market Size Growth Rate by Type: 2024 VS 2022 VS 2034
1.2.2 Adenovirus (AdV)
1.2.3 Adeno-associated Virus (AAV)
1.3 Market by Application
1.3.1 Global Viral Vector-Based Gene Therapy Market Growth by Application: 2024 VS 2022 VS 2034
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Vector-Based Gene Therapy Market Perspective (2024-2034)
2.2 Viral Vector-Based Gene Therapy Growth Trends by Region
2.2.1 Global Viral Vector-Based Gene Therapy Market Size by Region: 2024 VS 2022 VS 2034
2.2.2 Viral Vector-Based Gene Therapy Historic Market Size by Region (2024-2024)
2.2.3 Viral Vector-Based Gene Therapy Forecasted Market Size by Region (2024-2034)
2.3 Viral Vector-Based Gene Therapy Market Dynamics
2.3.1 Viral Vector-Based Gene Therapy Industry Trends
2.3.2 Viral Vector-Based Gene Therapy Market Drivers
2.3.3 Viral Vector-Based Gene Therapy Market Challenges
2.3.4 Viral Vector-Based Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Vector-Based Gene Therapy Players by Revenue
3.1.1 Global Top Viral Vector-Based Gene Therapy Players by Revenue (2024-2024)
3.1.2 Global Viral Vector-Based Gene Therapy Revenue Market Share by Players (2024-2024)
3.2 Global Viral Vector-Based Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Viral Vector-Based Gene Therapy Revenue
3.4 Global Viral Vector-Based Gene Therapy Market Concentration Ratio
3.4.1 Global Viral Vector-Based Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vector-Based Gene Therapy Revenue in 2022
3.5 Viral Vector-Based Gene Therapy Key Players Head office and Area Served
3.6 Key Players Viral Vector-Based Gene Therapy Product Solution and Service
3.7 Date of Enter into Viral Vector-Based Gene Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vector-Based Gene Therapy Breakdown Data by Type
4.1 Global Viral Vector-Based Gene Therapy Historic Market Size by Type (2024-2024)
4.2 Global Viral Vector-Based Gene Therapy Forecasted Market Size by Type (2024-2034)
5 Viral Vector-Based Gene Therapy Breakdown Data by Application
5.1 Global Viral Vector-Based Gene Therapy Historic Market Size by Application (2024-2024)
5.2 Global Viral Vector-Based Gene Therapy Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Viral Vector-Based Gene Therapy Market Size (2024-2034)
6.2 North America Viral Vector-Based Gene Therapy Market Growth Rate by Country: 2024 VS 2022 VS 2034
6.3 North America Viral Vector-Based Gene Therapy Market Size by Country (2024-2024)
6.4 North America Viral Vector-Based Gene Therapy Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Vector-Based Gene Therapy Market Size (2024-2034)
7.2 Europe Viral Vector-Based Gene Therapy Market Growth Rate by Country: 2024 VS 2022 VS 2034
7.3 Europe Viral Vector-Based Gene Therapy Market Size by Country (2024-2024)
7.4 Europe Viral Vector-Based Gene Therapy Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Vector-Based Gene Therapy Market Size (2024-2034)
8.2 Asia-Pacific Viral Vector-Based Gene Therapy Market Growth Rate by Region: 2024 VS 2022 VS 2034
8.3 Asia-Pacific Viral Vector-Based Gene Therapy Market Size by Region (2024-2024)
8.4 Asia-Pacific Viral Vector-Based Gene Therapy Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Vector-Based Gene Therapy Market Size (2024-2034)
9.2 Latin America Viral Vector-Based Gene Therapy Market Growth Rate by Country: 2024 VS 2022 VS 2034
9.3 Latin America Viral Vector-Based Gene Therapy Market Size by Country (2024-2024)
9.4 Latin America Viral Vector-Based Gene Therapy Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Vector-Based Gene Therapy Market Size (2024-2034)
10.2 Middle East & Africa Viral Vector-Based Gene Therapy Market Growth Rate by Country: 2024 VS 2022 VS 2034
10.3 Middle East & Africa Viral Vector-Based Gene Therapy Market Size by Country (2024-2024)
10.4 Middle East & Africa Viral Vector-Based Gene Therapy Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sibiono
11.1.1 Sibiono Company Detail
11.1.2 Sibiono Business Overview
11.1.3 Sibiono Viral Vector-Based Gene Therapy Introduction
11.1.4 Sibiono Revenue in Viral Vector-Based Gene Therapy Business (2024-2024)
11.1.5 Sibiono Recent Development
11.2 Rigvir Group
11.2.1 Rigvir Group Company Detail
11.2.2 Rigvir Group Business Overview
11.2.3 Rigvir Group Viral Vector-Based Gene Therapy Introduction
11.2.4 Rigvir Group Revenue in Viral Vector-Based Gene Therapy Business (2024-2024)
11.2.5 Rigvir Group Recent Development
11.3 Shanghai Pharma (Sunway)
11.3.1 Shanghai Pharma (Sunway) Company Detail
11.3.2 Shanghai Pharma (Sunway) Business Overview
11.3.3 Shanghai Pharma (Sunway) Viral Vector-Based Gene Therapy Introduction
11.3.4 Shanghai Pharma (Sunway) Revenue in Viral Vector-Based Gene Therapy Business (2024-2024)
11.3.5 Shanghai Pharma (Sunway) Recent Development
11.4 Amgen
11.4.1 Amgen Company Detail
11.4.2 Amgen Business Overview
11.4.3 Amgen Viral Vector-Based Gene Therapy Introduction
11.4.4 Amgen Revenue in Viral Vector-Based Gene Therapy Business (2024-2024)
11.4.5 Amgen Recent Development
11.5 Spark Therapeutics
11.5.1 Spark Therapeutics Company Detail
11.5.2 Spark Therapeutics Business Overview
11.5.3 Spark Therapeutics Viral Vector-Based Gene Therapy Introduction
11.5.4 Spark Therapeutics Revenue in Viral Vector-Based Gene Therapy Business (2024-2024)
11.5.5 Spark Therapeutics Recent Development
11.6 Novartis Gene Therapies
11.6.1 Novartis Gene Therapies Company Detail
11.6.2 Novartis Gene Therapies Business Overview
11.6.3 Novartis Gene Therapies Viral Vector-Based Gene Therapy Introduction
11.6.4 Novartis Gene Therapies Revenue in Viral Vector-Based Gene Therapy Business (2024-2024)
11.6.5 Novartis Gene Therapies Recent Development
11.7 Daiichi Sankyo
11.7.1 Daiichi Sankyo Company Detail
11.7.2 Daiichi Sankyo Business Overview
11.7.3 Daiichi Sankyo Viral Vector-Based Gene Therapy Introduction
11.7.4 Daiichi Sankyo Revenue in Viral Vector-Based Gene Therapy Business (2024-2024)
11.7.5 Daiichi Sankyo Recent Development
11.8 PTC Therapeutics
11.8.1 PTC Therapeutics Company Detail
11.8.2 PTC Therapeutics Business Overview
11.8.3 PTC Therapeutics Viral Vector-Based Gene Therapy Introduction
11.8.4 PTC Therapeutics Revenue in Viral Vector-Based Gene Therapy Business (2024-2024)
11.8.5 PTC Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Viral Vector-Based Gene Therapy Market Size Growth Rate by Type (US$ Million): 2024 VS 2022 VS 2034
Table 2. Key Players of Adenovirus (AdV)
Table 3. Key Players of Adeno-associated Virus (AAV)
Table 4. Global Viral Vector-Based Gene Therapy Market Size Growth by Application (US$ Million): 2024 VS 2022 VS 2034
Table 5. Global Viral Vector-Based Gene Therapy Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 6. Global Viral Vector-Based Gene Therapy Market Size by Region (2024-2024) & (US$ Million)
Table 7. Global Viral Vector-Based Gene Therapy Market Share by Region (2024-2024)
Table 8. Global Viral Vector-Based Gene Therapy Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 9. Global Viral Vector-Based Gene Therapy Market Share by Region (2024-2034)
Table 10. Viral Vector-Based Gene Therapy Market Trends
Table 11. Viral Vector-Based Gene Therapy Market Drivers
Table 12. Viral Vector-Based Gene Therapy Market Challenges
Table 13. Viral Vector-Based Gene Therapy Market Restraints
Table 14. Global Viral Vector-Based Gene Therapy Revenue by Players (2024-2024) & (US$ Million)
Table 15. Global Viral Vector-Based Gene Therapy Market Share by Players (2024-2024)
Table 16. Global Top Viral Vector-Based Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector-Based Gene Therapy as of 2022)
Table 17. Ranking of Global Top Viral Vector-Based Gene Therapy Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Viral Vector-Based Gene Therapy Revenue (CR5 and HHI) & (2024-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Viral Vector-Based Gene Therapy Product Solution and Service
Table 21. Date of Enter into Viral Vector-Based Gene Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Viral Vector-Based Gene Therapy Market Size by Type (2024-2024) & (US$ Million)
Table 24. Global Viral Vector-Based Gene Therapy Revenue Market Share by Type (2024-2024)
Table 25. Global Viral Vector-Based Gene Therapy Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 26. Global Viral Vector-Based Gene Therapy Revenue Market Share by Type (2024-2034)
Table 27. Global Viral Vector-Based Gene Therapy Market Size by Application (2024-2024) & (US$ Million)
Table 28. Global Viral Vector-Based Gene Therapy Revenue Market Share by Application (2024-2024)
Table 29. Global Viral Vector-Based Gene Therapy Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 30. Global Viral Vector-Based Gene Therapy Revenue Market Share by Application (2024-2034)
Table 31. North America Viral Vector-Based Gene Therapy Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 32. North America Viral Vector-Based Gene Therapy Market Size by Country (2024-2024) & (US$ Million)
Table 33. North America Viral Vector-Based Gene Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 34. Europe Viral Vector-Based Gene Therapy Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 35. Europe Viral Vector-Based Gene Therapy Market Size by Country (2024-2024) & (US$ Million)
Table 36. Europe Viral Vector-Based Gene Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 37. Asia-Pacific Viral Vector-Based Gene Therapy Market Size Growth Rate by Region (US$ Million): 2024 VS 2022 VS 2034
Table 38. Asia-Pacific Viral Vector-Based Gene Therapy Market Size by Region (2024-2024) & (US$ Million)
Table 39. Asia-Pacific Viral Vector-Based Gene Therapy Market Size by Region (2024-2034) & (US$ Million)
Table 40. Latin America Viral Vector-Based Gene Therapy Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 41. Latin America Viral Vector-Based Gene Therapy Market Size by Country (2024-2024) & (US$ Million)
Table 42. Latin America Viral Vector-Based Gene Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 43. Middle East & Africa Viral Vector-Based Gene Therapy Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 44. Middle East & Africa Viral Vector-Based Gene Therapy Market Size by Country (2024-2024) & (US$ Million)
Table 45. Middle East & Africa Viral Vector-Based Gene Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 46. Sibiono Company Detail
Table 47. Sibiono Business Overview
Table 48. Sibiono Viral Vector-Based Gene Therapy Product
Table 49. Sibiono Revenue in Viral Vector-Based Gene Therapy Business (2024-2024) & (US$ Million)
Table 50. Sibiono Recent Development
Table 51. Rigvir Group Company Detail
Table 52. Rigvir Group Business Overview
Table 53. Rigvir Group Viral Vector-Based Gene Therapy Product
Table 54. Rigvir Group Revenue in Viral Vector-Based Gene Therapy Business (2024-2024) & (US$ Million)
Table 55. Rigvir Group Recent Development
Table 56. Shanghai Pharma (Sunway) Company Detail
Table 57. Shanghai Pharma (Sunway) Business Overview
Table 58. Shanghai Pharma (Sunway) Viral Vector-Based Gene Therapy Product
Table 59. Shanghai Pharma (Sunway) Revenue in Viral Vector-Based Gene Therapy Business (2024-2024) & (US$ Million)
Table 60. Shanghai Pharma (Sunway) Recent Development
Table 61. Amgen Company Detail
Table 62. Amgen Business Overview
Table 63. Amgen Viral Vector-Based Gene Therapy Product
Table 64. Amgen Revenue in Viral Vector-Based Gene Therapy Business (2024-2024) & (US$ Million)
Table 65. Amgen Recent Development
Table 66. Spark Therapeutics Company Detail
Table 67. Spark Therapeutics Business Overview
Table 68. Spark Therapeutics Viral Vector-Based Gene Therapy Product
Table 69. Spark Therapeutics Revenue in Viral Vector-Based Gene Therapy Business (2024-2024) & (US$ Million)
Table 70. Spark Therapeutics Recent Development
Table 71. Novartis Gene Therapies Company Detail
Table 72. Novartis Gene Therapies Business Overview
Table 73. Novartis Gene Therapies Viral Vector-Based Gene Therapy Product
Table 74. Novartis Gene Therapies Revenue in Viral Vector-Based Gene Therapy Business (2024-2024) & (US$ Million)
Table 75. Novartis Gene Therapies Recent Development
Table 76. Daiichi Sankyo Company Detail
Table 77. Daiichi Sankyo Business Overview
Table 78. Daiichi Sankyo Viral Vector-Based Gene Therapy Product
Table 79. Daiichi Sankyo Revenue in Viral Vector-Based Gene Therapy Business (2024-2024) & (US$ Million)
Table 80. Daiichi Sankyo Recent Development
Table 81. PTC Therapeutics Company Detail
Table 82. PTC Therapeutics Business Overview
Table 83. PTC Therapeutics Viral Vector-Based Gene Therapy Product
Table 84. PTC Therapeutics Revenue in Viral Vector-Based Gene Therapy Business (2024-2024) & (US$ Million)
Table 85. PTC Therapeutics Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Viral Vector-Based Gene Therapy Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Viral Vector-Based Gene Therapy Market Share by Type: 2022 VS 2034
Figure 3. Adenovirus (AdV) Features
Figure 4. Adeno-associated Virus (AAV) Features
Figure 5. Global Viral Vector-Based Gene Therapy Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global Viral Vector-Based Gene Therapy Market Share by Application: 2022 VS 2034
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Viral Vector-Based Gene Therapy Report Years Considered
Figure 11. Global Viral Vector-Based Gene Therapy Market Size (US$ Million), Year-over-Year: 2024-2034
Figure 12. Global Viral Vector-Based Gene Therapy Market Size, (US$ Million), 2024 VS 2022 VS 2034
Figure 13. Global Viral Vector-Based Gene Therapy Market Share by Region: 2022 VS 2034
Figure 14. Global Viral Vector-Based Gene Therapy Market Share by Players in 2022
Figure 15. Global Top Viral Vector-Based Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector-Based Gene Therapy as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Viral Vector-Based Gene Therapy Revenue in 2022
Figure 17. North America Viral Vector-Based Gene Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 18. North America Viral Vector-Based Gene Therapy Market Share by Country (2024-2034)
Figure 19. United States Viral Vector-Based Gene Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 20. Canada Viral Vector-Based Gene Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 21. Europe Viral Vector-Based Gene Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 22. Europe Viral Vector-Based Gene Therapy Market Share by Country (2024-2034)
Figure 23. Germany Viral Vector-Based Gene Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 24. France Viral Vector-Based Gene Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 25. U.K. Viral Vector-Based Gene Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 26. Italy Viral Vector-Based Gene Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 27. Russia Viral Vector-Based Gene Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 28. Nordic Countries Viral Vector-Based Gene Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 29. Asia-Pacific Viral Vector-Based Gene Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 30. Asia-Pacific Viral Vector-Based Gene Therapy Market Share by Region (2024-2034)
Figure 31. China Viral Vector-Based Gene Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 32. Japan Viral Vector-Based Gene Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 33. South Korea Viral Vector-Based Gene Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 34. Southeast Asia Viral Vector-Based Gene Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 35. India Viral Vector-Based Gene Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 36. Australia Viral Vector-Based Gene Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 37. Latin America Viral Vector-Based Gene Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 38. Latin America Viral Vector-Based Gene Therapy Market Share by Country (2024-2034)
Figure 39. Mexico Viral Vector-Based Gene Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 40. Brazil Viral Vector-Based Gene Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 41. Middle East & Africa Viral Vector-Based Gene Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 42. Middle East & Africa Viral Vector-Based Gene Therapy Market Share by Country (2024-2034)
Figure 43. Turkey Viral Vector-Based Gene Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 44. Saudi Arabia Viral Vector-Based Gene Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 45. Sibiono Revenue Growth Rate in Viral Vector-Based Gene Therapy Business (2024-2024)
Figure 46. Rigvir Group Revenue Growth Rate in Viral Vector-Based Gene Therapy Business (2024-2024)
Figure 47. Shanghai Pharma (Sunway) Revenue Growth Rate in Viral Vector-Based Gene Therapy Business (2024-2024)
Figure 48. Amgen Revenue Growth Rate in Viral Vector-Based Gene Therapy Business (2024-2024)
Figure 49. Spark Therapeutics Revenue Growth Rate in Viral Vector-Based Gene Therapy Business (2024-2024)
Figure 50. Novartis Gene Therapies Revenue Growth Rate in Viral Vector-Based Gene Therapy Business (2024-2024)
Figure 51. Daiichi Sankyo Revenue Growth Rate in Viral Vector-Based Gene Therapy Business (2024-2024)
Figure 52. PTC Therapeutics Revenue Growth Rate in Viral Vector-Based Gene Therapy Business (2024-2024)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed